Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Patch for Postoperative Pain After Third Molar Extraction
NCT07330726Phase 3Not yet recruiting
- Sponsor
- Fayoum University
- Start
- Jan 2026
- Primary completion
- Apr 2026
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of lidocaine 10% oropharyngeal spray in postoperative pain (2 arms), sponsored by Fayoum University. Primary endpoint: Pain intensity at 7 days. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07330726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07330726.